{"entity":{"id":"nct06630234","kind":"trial","name":"A Master Protocol to Evaluate DCC-3009 in Gastrointestinal Stromal Tumor (GIST)","aka":[],"tldr":"A phase 1/2 trial of DCC-3009 in gastrointestinal stromal tumour, run by Deciphera Pharmaceuticals, LLC, now recruiting.","summary":"A Master Protocol to Evaluate DCC-3009 in Gastrointestinal Stromal Tumor (GIST) is a phase 1/2 interventional study registered as NCT06630234 by Deciphera Pharmaceuticals, LLC, with 120 participants planned, started 2024-12-10 and due to reach its primary completion in 2028-05. Interventions recorded: DCC-3009.","status":"recruiting","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT06630234","url":"https://clinicaltrials.gov/study/NCT06630234"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["gist"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":["deciphera"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"nct":"NCT06630234","phase":"1/2","setting":"A Master Protocol for the Multi-cohort, Open-label, Phase 1/2 Study of DCC-3009 in Participants With Gastrointestinal Stromal Tumor (GIST)","sponsor":"Deciphera Pharmaceuticals, LLC","enrolled":120,"outcomes":[]},"route":"/trials/nct06630234/","neighbours":{"cancer":[{"id":"gist","kind":"cancer","name":"Gastrointestinal stromal tumour (GIST)","route":"/cancers/gist/"}],"company":[{"id":"deciphera","kind":"company","name":"Deciphera Pharmaceuticals (Ono)","route":"/companies/deciphera/"}]}}